Logo image of LXRX

LEXICON PHARMACEUTICALS INC (LXRX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:LXRX - US5288723027 - Common Stock

1.43 USD
0 (0%)
Last: 11/28/2025, 7:44:21 PM
1.42 USD
-0.01 (-0.7%)
After Hours: 11/28/2025, 7:44:21 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
LXRX revenue by date.LXRX revenue by date.
100K
-66.67%
1.204M
1,104.00%
31.081M
2,481.48%
51.765M
66.55%
12.494M
-75.86%
28.186M
125.60%
62.106M
120.34%
108.29M
74.36%
196.32M
81.29%
328.32M
67.24%
516.43M
57.29%
EBITDA
YoY % growth
LXRX ebitda by date.LXRX ebitda by date.
-100.4M
-15.67%
-171.196M
-70.51%
-196.583M
-14.83%
-79.719M
59.45%
-114.822M
-44.03%
-117.965M
-2.74%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
LXRX ebit by date.LXRX ebit by date.
-100.8M
-15.73%
-171.75M
-70.39%
-197.117M
-14.77%
-79.529M
59.65%
-113.359M
-42.54%
-105.117M
7.27%
-119.804M
-13.97%
-28.437M
76.26%
74.665M
362.57%
210.94M
182.52%
397.44M
88.41%
Operating Margin
LXRX operating margin by date.LXRX operating margin by date.
-100,800.00%-14,264.95%-634.20%-153.64%-907.31%-372.94%-192.90%-26.26%38.03%64.25%76.96%
EPS
YoY % growth
LXRX eps by date.LXRX eps by date.
-0.61
0.00%
-0.80
-31.15%
-0.64
20.00%
-0.20
69.21%
-0.28
-42.03%
-0.21
24.56%
-0.14
33.96%
-0.08
41.48%
0.20
350.00%
0.57
180.00%
1.08
89.29%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.07
19.25%
-0.07
5.29%
-0.07
-814.00%
-0.07
-78.50%
-0.07
8.77%
Revenue
Q2Q % growth
3.204M
-87.93%
5.763M
356.66%
5.865M
-79.68%
7.395M
-47.86%
5.115M
59.64%
EBITDA
Q2Q % growth
-27.941M
13.23%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-28.408M
13.22%
-25.124M
2.16%
-26.098M
-798.55%
-26.677M
-118.89%
-28.102M
1.08%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.04
77.78%
-0.070.0340.58%
Q2 2025
Q2Q % growth
0.01
105.88%
-0.080.09112.65%
Q1 2025
Q2Q % growth
-0.07
65.00%
-0.100.0329.61%
Q4 2024
Q2Q % growth
-0.09
55.00%
-0.130.0430.70%
Q3 2024
Q2Q % growth
-0.18
14.29%
-0.17-0.01-7.28%
Q2 2024
Q2Q % growth
-0.17
22.73%
-0.190.0211.66%
Q1 2024
Q2Q % growth
-0.20
-17.65%
-0.200.000.72%
Q4 2023
Q2Q % growth
-0.20
-25.00%
-0.220.029.75%
Q3 2023
Q2Q % growth
-0.21
-61.54%
-0.220.014.13%
Q2 2023
Q2Q % growth
-0.22
-37.50%
-0.18-0.04-23.43%
Q1 2023
Q2Q % growth
-0.17
-6.25%
-0.180.017.02%
Q4 2022
Q2Q % growth
-0.16
5.88%
-0.14-0.02-17.06%
Q3 2022
Q2Q % growth
-0.13
18.75%
-0.140.018.53%
Q2 2022
Q2Q % growth
-0.16
-23.08%
-0.160.000.30%
Q1 2022
Q2Q % growth
-0.16
-6.67%
-0.170.014.74%
Q4 2021
Q2Q % growth
-0.17
-325.00%
-0.190.028.76%
Q3 2021
Q2Q % growth
-0.16
-122.86%
-0.180.0211.38%
Q2 2021
Q2Q % growth
-0.13
79.37%
-0.160.0320.22%
Q1 2021
Q2Q % growth
-0.15
76.19%
-0.160.016.57%
Q4 2020
Q2Q % growth
-0.04
91.67%
-0.280.2485.82%
Q3 2020
Q2Q % growth
0.70
-66.82%
0.270.43160.20%
Q2 2020
Q2Q % growth
-0.63
-186.36%
-0.62-0.01-1.63%
Q1 2020
Q2Q % growth
-0.63
-200.00%
-0.710.0811.08%
Q4 2019
Q2Q % growth
-0.48 -0.790.3139.00%
Q3 2019
Q2Q % growth
2.11 0.741.37183.84%
Q2 2019
Q2Q % growth
-0.22 -0.08-0.14-180.11%
Q1 2019
Q2Q % growth
-0.21 -0.230.027.68%
LXRX Yearly EPS VS EstimatesLXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.5 -0.5 1 -1 -1.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
14.182M
710.40%
4.742M9.44M199.07%
Q2 2025
Q2Q % growth
28.866M
1,652.64%
4.965M23.901M481.39%
Q1 2025
Q2Q % growth
1.262M
11.68%
1.441M-179K-12.42%
Q4 2024
Q2Q % growth
26.554M
3,682.62%
6.61M19.944M301.72%
Q3 2024
Q2Q % growth
1.75M
980.25%
2.988M-1.238M-41.43%
Q2 2024
Q2Q % growth
1.647M
419.56%
2.887M-1.24M-42.95%
Q1 2024
Q2Q % growth
1.13M
4,608.33%
1.429M-299K-20.92%
Q4 2023
Q2Q % growth
702K 1.267M-565K-44.59%
Q3 2023
Q2Q % growth
162K 2.101M-1.939M-92.29%
Q2 2023
Q2Q % growth
317K 68.003K248.997K366.15%
Q1 2023
Q2Q % growth
24K 33.997K-9.997K-29.40%
Q4 2022
Q2Q % growth
51K-51K-100.00%
Q3 2022
Q2Q % growth
51K-51K-100.00%
Q2 2022
Q2Q % growth

-100.00%
51K-51K-100.00%
Q1 2022
Q2Q % growth
51K-51K-100.00%
Q4 2021
Q2Q % growth

-100.00%
%
Q3 2021
Q2Q % growth

-100.00%
%
Q2 2021
Q2Q % growth
200K
-97.83%
9.18K190.82K2,078.65%
Q1 2021
Q2Q % growth

-100.00%
1.71M-1.71M-100.00%
Q4 2020
Q2Q % growth
200K
-97.70%
112.2K87.8K78.25%
Q3 2020
Q2Q % growth
6.6M
-97.76%
17.21M-10.61M-61.65%
Q2 2020
Q2Q % growth
9.2M
-5.15%
9.006M194K2.15%
Q1 2020
Q2Q % growth
8M
-13.04%
7.944M56K0.70%
Q4 2019
Q2Q % growth
8.7M 10.471M-1.771M-16.91%
Q3 2019
Q2Q % growth
294.4M 65.535M228.865M349.23%
Q2 2019
Q2Q % growth
9.7M 29.089M-19.389M-66.65%
Q1 2019
Q2Q % growth
9.2M 13.532M-4.332M-32.01%
LXRX Yearly Revenue VS EstimatesLXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-5.56% 8.06% 0% 17.15%
Revenue-44.62% -7.48% 0% 79.65%